The effect of nitric oxide synthase inhibitor on form-deprivation myopia

Curr Eye Res. 1997 Oct;16(10):992-6. doi: 10.1076/ceyr.16.10.992.9021.

Abstract

Purpose: Form-deprivation myopia (FDM) is believed to result principally from actions of substances that modulate information processing in the retina. We used a chick model to investigate what role nitric oxide (NO), a gaseous neuromodulator, might play in the development of FDM.

Methods: We injected different concentrations of the NO synthase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) (30 ml) into the left eyes and the same volume of saline into the right eyes of 6-day-old chicks. Both eyes of most chicks were occluded for 6 days with translucent goggles. After removal of the goggles, the refraction was measured by retinoscopy and the axial lengths with an A-mode ultrasound. In some chicks we measured the concentration of NOx (nitrite and nitrate) in the retina. A few chicks, not wearing occluders after injection of L-NAME and saline, ERG and refraction, were examined 6 days after the treatment.

Results: In chicks that wore occluders, refractive error and axial length were significantly less affected in eyes injected with L-NAME (180, 360, or 540 mM) compared to control (right) eyes. ERG changes were reversible, except in eyes injected with the highest concentration (540 mM) of L-NAME. The eyes of chicks, injected with L-NAME and reared without occlusion, had normal refractive values. After 6 days of form deprivation, the concentration of NOx in the retina of eyes injected with L-NAME (180 mM) was significantly less than the concentration in eyes injected with saline.

Conclusions: The injection of L-NAME before occlusion of developing chick eyes leads to reversible modifications in retinal function and inhibits the development of form-deprivation myopia.

MeSH terms

  • Animals
  • Chickens
  • Electroretinography
  • Enzyme Inhibitors / pharmacology*
  • Form Perception
  • Myopia / etiology
  • Myopia / physiopathology
  • Myopia / prevention & control*
  • NG-Nitroarginine Methyl Ester / pharmacology*
  • Nitrates / metabolism
  • Nitric Oxide / physiology
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitrites / metabolism
  • Refraction, Ocular
  • Retina / drug effects
  • Retina / metabolism
  • Retina / physiopathology
  • Sensory Deprivation*

Substances

  • Enzyme Inhibitors
  • Nitrates
  • Nitrites
  • Nitric Oxide
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester